Renub

    Switzerland Diabetes Market, Size, Forecast 2023-2028, By SMBG Device, Continuous Glucose Monitoring (CGM), Insulin Pen, Insulin Pump, and Company Analysis

    Excel: 8 Hours
    PDF: 24 Hours
    Mar 2023
    Pages: 190

    Switzerland Diabetes Market Outlook

    Switzerland Diabetes Market will reach US$ 1.99 Billion at a CAGR of 4.71% by 2028, according to Renub Research. Almost half a million people in Switzerland have diabetes, which is constantly rising. Diabetes is an essential public health paging, one of four priority non-infectious diseases targeted for action by world leaders. The prevalence of Swiss Diabetes has been steadily increasing over the past few decades. Due to population boost, urbanization, aging, and the rising prevalence of obesity, the number of individuals with Diabetes is growing. Improving glycemic control is associated with reducing late complications of Diabetes, such as cardiovascular and micro vascular diseases. Therefore, treatment guidelines were established internationally by prominent and renowned associations and adopted by many countries.


    switzerland-diabetes-market


    Type 2 Diabetes is Increasing Year on Year

    In Switzerland, Diabetes affects approximately 5% of the population; type 2 diabetes, the most common type, affects about 500,000 people, while type 1 diabetes affects about 40,000 people, according to the Swiss Medical Net. Diabetes can lead to complications in many body parts and increase the risk of dying prematurely. Possible complications include kidney failure, leg amputation, heart attack, stroke, nerve damage, and vision loss.

    In addition, patients with T2D must have a BMI of ≥ 28 kg/m2 for health insurance to reimburse semaglutide treatment. This may have had implications for the patients enrolled in SURE Switzerland. According to our research study Diabetes Market in Switzerland was valued at US$ 1.51 Billion in 2022.


    Increasing Number of Diabetes in Switzerland will create more demand for Insulin Pen Market

    Based on devices, Switzerland Diabetes Market is classified into four types:  Glucose Monitoring (CGM), Self-Monitoring Blood Glucose (SMBG), and Insulin Pump and Insulin Pens. Insulin pens will hold the maximum share during the upcoming years due to the rising prevalence of Diabetes in various age groups; increasing R&D activities also boost the insulin pen market. Currently, over 95% of the insulin used in Switzerland is sold in a concentration of 40 units per ml. However, only recently, a small but increasing amount of more concentrated insulin has been introduced through "pen" injectors designed for U-100 (= 100 units per ml) insulin.

    With the greater ease of use of insulin pens, people in Switzerland with visual impairment or reduced dexterity may significantly benefit from using an insulin pen rather than a vial and syringe. However, once in use, most insulin analog vials, cartridges, and prefilled pens must be discarded after 28 days. Moreover, SMBG, Insulin Pumps, and CMG will also grow in Switzerland during the upcoming year. The Insulin Pump is especially suitable for patients with type-1 Diabetes who require a continuous supply of insulin and need to balance every meal with additional insulin.


    Switzerland Health Policy

    The Swiss healthcare system's duties and responsibilities are divided among cantonal, federal and municipal governments. Each of the 26 cantons was responsible for licensing providers, coordinating hospital services, promoting health through disease prevention, and subsidizing institutions and individual premiums. The federal government regulates system financing, ensures the safety and quality of pharmaceuticals and medical devices, oversees public health initiatives, and promotes research and training. The municipalities organize and provide long-term care (nursing home care and home care services) and other social support services for vulnerable groups.


    Key Company

    The Netherlands Diabetes Market comprises major manufacturers, B. Braun Melsungen AG, Sanofi, Eli Lilly and Company, Becton Dickenson (BD), Novo Nordisk A/S, Ypsomed AG, Biocon, Medtronic, Insulet Corporation, Abbott Laboratories, Terumo Corporation, and Dexcom Inc.

    • In May 2021, Medtronic secured European approvals for its Guardian 4 sensor. The Guardian 4 sensor can be either utilized as a standalone continuous glucose monitor or combined into Medtronic's insulin pumps and pens to add real-time glucose monitoring alongside insulin tracking.


    Renub Research report titled “Switzerland  Diabetes Market & Forecast, By Continuous Glucose Monitoring Analysis (Glucose Sensor Market &Forecast, CGM Transmitter Market& Forecast, CGM User, and CGM Reimbursement), Self-Monitoring Blood GlucoseAnalysis(Test Strips Market& Forecast, Lancet Market & Forecast, Meter Market and Forecast, Blood Glucose (SMBG)  Users and Blood Glucose Devices Reimbursement), Insulin Pen Analysis (Disposable Insulin Pen, Reusable Insulin Pen, Smart Insulin Pen, insulin Pen Needle Market, insulin Pen Users, and reimbursement Policies), Insulin Pump Analysis (Insulin Pump Market, Insulin Pump Users, Insulin Pump Products and Reimbursement), Companies (B. Braun Melsungen AG, Eli Lilly and Company, Terumo Corporation, Becton, Dickinson (BD), Novo Nardisk, Ypsomed AG, Medtronic, Insulet Cororation, Abbott Laboratories, DarioHealth Crop, Dexcom, Inc, Roche Diagnostic, Tandem Diabetes Care)” provides a complete analysis of Switzerland Diabetes Market.

    switzerland-diabetes-market-share


    Switzerland Segments Market based on Devices

    Segments Market based on Devices

    1.    Continuous Glucose Monitoring (CGM)
    2.    Self-Monitoring Blood Glucose (SMBG)
    3.    Insulin Pen
    4.    Insulin Pump


    Switzerland Diabetes Sub-Segment Analysis

    1. Continuous Glucose Monitoring (CGM)

    1.    Glucose Sensor Market & Forecast
    2.    CGM Transmitter Market & Forecast
    3.    CGM User
    4.    CGM Reimbursement


    2. SMBG

    1.    Test Strips Market and Forecast
    2.    Lancet Market and Forecast
    3.    Meter Market and Forecast
    4.    Blood Glucose (SMBG) Users
    5.    Blood Glucose Devices Reimbursement


    3. Insulin Pen Market

    1.    Disposable Insulin Pen
    2.    Reusable Insulin Pen
    3.    Smart Insulin Pen
    4.    Insulin Pen Needle Market
    5.    Insulin Pen Users
    6.    Reimbursement Policies


    4. Insulin Pump Market

    1.    Insulin Pump Market
    2.    Insulin Pump Users
    3.    Insulin Pump Products
    4.    Reimbursement Policies


    All the 13 Companies Studied in the Report have been Studied from 3 Points

    •    Company Overview
    •    Recent Developments
    •    Financial Insight


    Company Analysis

    1.    B. Braun Melsungen AG
    2.    Eli Lilly and Company
    3.    Terumo Corporation
    4.    Becton, Dickinson (BD)
    5.    Novo Nardisk
    6.    Ypsomed AG
    7.    Medtronic
    8.    Insulet Cororation
    9.    Abbott Laboratories
    10.    DarioHealth Crop
    11.    Dexcom, Inc
    12.    Roche Diagnostic
    13.    Tandem Diabetes Care


    Report Details:

    Report Features Details
    Base Year 2022
    Historical Period 2017 - 2022
    Forecast Period 2023 - 2028
    Market US$ Billion
    Segment Covered CGM, SMBG, Insulin Pump, and Insulin Pen
    Companies Covered B. Braun Melsungen AG, Eli Lilly and Company, Terumo Corporation, Becton, Dickinson (BD), Novo Nardisk, Ypsomed AG, Medtronic, Insulet Cororation, Abbott Laboratories, DarioHealth Crop, Dexcom, Inc, Roche Diagnostic, and Tandem Diabetes Care
    Customization Scope 20% Free Customization
    Post-Sale Analyst Support 1 Year (52 Weeks)
    Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on request)


    Key Benefits of the Report

    • This report provides current market estimates and forecasts for Switzerland Diabetic Market.
    • Detailed analysis of the key market segments such as source, geography and applications; provides a comprehensive understanding of the market.
    • Detailed analysis of Switzerland SMBG Market.
    • Detailed analysis of Switzerland CGM Market.
    • Detailed analysis of Switzerland Insulin Pump Market.
    • Detailed analysis of Switzerland Insulin Pen Market.
    • Switzerland Diabetic Market – Growth Drivers and Challenges.
    • Key sustainability strategies adopted by market players.

    1.    Introduction

    2.    Research & Methodology

    3.    Executive Summary

    4.    Market Dynamics

    4.1    Growth Drivers
    4.2    Challenges


    5.    Switzerland Diabetes Market

    6.    Switzerland Diabetes Population

    6.1    Type 1 Diabetes
    6.2    Type 2 Diabetes


    7.    Switzerland Diabetes Market Share Analysis

    7.1    By Types


    8.    Continuous Glucose Monitoring Market (CGM) – Market & Users

    8.1    Switzerland - CGM Market by Components

    8.1.1    Glucose Sensor Market
    8.1.2    CGM Transmitter Market

    8.2    CGM User
    8.3    Reimbursement Policies of CGM Devices in Switzerland


    9.    Blood Glucose Device (SMBG) – Switzerland Market & Users

    9.1    Market

    9.1.1    Type 1 Diabetes Market
    9.1.2     Type 2 Diabetes Market

    9.2    Test Strips Market

    9.2.1    Type 1 Diabetes
    9.2.2    Type 2 Diabetes

    9.3    Lancet Market

    9.3.1    Type 1 Diabetes
    9.3.2    Type 2 Diabetes

    9.4    Meter Market and Forecast

    9.4.1    Type 1 Diabetes
    9.4.2    Type 2 Diabetes

    9.5    Blood Glucose (SMBG) Users

    9.5.1    Type 1 Diabetes
    9.5.2    Type 2 Diabetes

    9.6    Reimbursement Policies of Blood Glucose Devices in Switzerland


    10.    Insulin Pen – Switzerland Market & User Analysis

    10.1    Insulin Pen Market

    10.1.1    Disposable Insulin Pen Market
    10.1.2    Reusable Insulin Pen Market
    10.1.3    Smart Insulin Pen Market

    10.2    Insulin Pen Needle Market

    10.3    Insulin Pen User

    10.3.1    Disposable Insulin Pen User
    10.3.2    Reusable Insulin Pen User
    10.3.3    Smart Insulin Pen User

    10.4    Reimbursement Policies of Insulin Pen in Switzerland


    11.    Insulin Pump - Switzerland Market & Users

    11.1    Insulin Pump Market

    11.1.1    Type 1 Diabetes Market
    11.1.2    Type 2 Diabetes Market

    11.2    Insulin Pump User

    11.2.1    Type 1 Insulin Pump User
    11.2.2    Type 2 Insulin Pump User

    11.3    Differentiation Points of Insulin Pump Products in Switzerland


    12.    Insulin Pen – Company Analysis

    12.1    B. Braun Melsungen AG

    12.1.1    Overview
    12.1.2    Recent Developments
    12.1.3    Revenue

    12.2    Eli Lilly

    12.2.1    Overview
    12.2.2    Recent Developments
    12.2.3    Revenue

    12.3    Terumo Corporation

    12.3.1    Overview
    12.3.2    Recent Developments
    12.3.3    Revenue

    12.4    BD

    12.4.1    Overview
    12.4.2    Recent Developments
    12.4.3    Revenue

    12.5    Novo Nordisk A/S

    12.5.1    Overview
    12.5.2    Recent Developments
    12.5.3    Revenue

    12.6    Ypsomed AG

    12.6.1    Overview
    12.6.2    Recent Developments
    12.6.3    Revenue


    13.    Insulin Pump – Company Analysis

    13.1    Medtronic

    13.1.1    Overview
    13.1.2    Recent Developments
    13.1.3    Revenue

    13.2    Insulet Corporation

    13.2.1    Overview
    13.2.2    Recent Developments
    13.2.3    Revenue


    14.    SMBG – Company Analysis

    14.1    DarioHealth Corp

    14.1.1    Overview
    14.1.2    Recent Developments
    14.1.3    Revenue

    14.2    Abbott Laboratories

    14.2.1    Overview
    14.2.2    Recent Developments
    14.2.3    Revenue


    15.    CGM – Company Analysis

    15.1    Dexcom Inc

    15.1.1    Overview
    15.1.2    Recent Developments
    15.1.3    Revenue

    15.2    Roche

    15.2.1    Overview
    15.2.2    Recent Developments
    15.2.3    Revenue

    15.3    Tandem Diabetes Care

    15.3.1    Overview
    15.3.2    Recent Developments
    15.3.3    Revenue


    List of Figures:

    Figure-01:    Switzerland – Diabetes Market (Billion US$), 2017 – 2022
    Figure-02:    Switzerland – Forecast for Diabetes Market (Billion US$), 2023 – 2028
    Figure-03:    Switzerland – Type 1 Diabetes Population (Thousand), 2017 – 2022
    Figure-04:    Switzerland – Forecast for Type 1 Diabetes Population (Thousand), 2023 – 2028
    Figure-05:    Switzerland – Type 2 Diabetes Population (Thousand), 2017 – 2022
    Figure-06:    Switzerland – Forecast for Type 2 Diabetes Population (Thousand), 2023 – 2028
    Figure-07:    Switzerland – Glucose Sensor Market (Million US$), 2017 – 2023
    Figure-08:    Switzerland – Forecast for Glucose Sensor Market (Million US$), 2023 – 2028
    Figure-09:    Switzerland – CGM Transmitter Market (Million US$), 2017 – 2023
    Figure-10:    Switzerland – Forecast for CGM Transmitter Market (Million US$), 2023 – 2028
    Figure-11:    Switzerland – CGM User (Number), 2017 – 2023
    Figure-12:    Switzerland – Forecast for CGM User (Number), 2023 – 2028
    Figure-13:    Switzerland – Self-Monitoring of Blood Glucose (SMBG) Type 1 Diabetes Market (Million US$), 2023 – 2028
    Figure-14:    Switzerland – Forecast for Self-Monitoring of Blood Glucose (SMBG) Type 1 Diabetes Market (Million US$), 2017 – 2023
    Figure-15:    Switzerland – Self-Monitoring of Blood Glucose (SMBG) Type 2 Diabetes Market (Million US$), 2023 – 2028
    Figure-16:    Switzerland – Forecast for Self-Monitoring of Blood Glucose (SMBG) Type 2 Diabetes Market (Million US$), 2017 – 2023
    Figure-17:    Switzerland – Test Strips Type 1 Diabetes Market (Million US$), 2023 – 2028
    Figure-18:    Switzerland – Forecast for Test Strips Type 1 Diabetes Market (Million US$), 2017 – 2023
    Figure-19:    Switzerland – Test Strips Type 2 Diabetes Market (Million US$), 2023 – 2028
    Figure-20:    Switzerland – Forecast for Test Strips Type 2 Diabetes Market (Million US$), 2017 – 2023
    Figure-21:    Switzerland – Lancet Type 1 Diabetes Market (Million US$), 2023 – 2028
    Figure-22:    Switzerland – Forecast for Lancet Type 1 Diabetes Market (Million US$), 2017 – 2023
    Figure-23:    Switzerland – Lancet Type 2 Diabetes Market (Million US$), 2023 – 2028
    Figure-24:    Switzerland – Forecast for Lancet Type 2 Diabetes Market (Million US$), 2017 – 2023
    Figure-25:    Switzerland – Meter Type 1 Diabetes Market (Million US$), 2023 – 2028
    Figure-26:    Switzerland – Forecast for Meter Type 1 Diabetes Market (Million US$), 2017 – 2023
    Figure-27:    Switzerland – Meter Type 2 Diabetes Market (Million US$), 2023 – 2028
    Figure-28:    Switzerland – Forecast for Meter Type 2 Diabetes Market (Million US$), 2017 – 2023
    Figure-29:    Switzerland – Self-Monitoring of Blood Glucose (SMBG) Type 1 Users (Thousand), 2017 – 2022
    Figure-30:    Switzerland – Forecast for Self-Monitoring of Blood Glucose (SMBG) Type 1 Users (Thousand), 2023 – 2028
    Figure-31:    Switzerland – Self-Monitoring of Blood Glucose (SMBG) Type 2 Users (Thousand), 2017 – 2022
    Figure-32:    Switzerland – Forecast for Self-Monitoring of Blood Glucose (SMBG) Type 2 Users (Thousand), 2023 – 2028
    Figure-33:    Switzerland – Disposable Insulin Pen Market (Million US$), 2017 – 2023
    Figure-34:    Switzerland – Forecast for Disposable Insulin Pen Market (Million US$), 2023 – 2028
    Figure-35:    Switzerland – Reusable Insulin Pen Market (Million US$), 2017 – 2023
    Figure-36:    Switzerland – Forecast for Reusable Insulin Pen Market (Million US$), 2023 – 2028
    Figure-37:    Switzerland – Smart Insulin Pen Market (Million US$), 2017 – 2023
    Figure-38:    Switzerland – Forecast for Smart Insulin Pen Market (Million US$), 2023 – 2028
    Figure-45:    Switzerland – Insulin Pen Needle Market (Million US$), 2017 – 2023
    Figure-46:    Switzerland – Forecast for Pen Needle Market (Million US$), 2023 – 2028
    Figure-39:    Switzerland – Disposable Insulin Pen User (Thousand), 2017 – 2022
    Figure-40:    Switzerland – Forecast for Disposable Insulin Pen User (Thousand), 2023 – 2028
    Figure-41:    Switzerland – Reusable Insulin Pen User (Thousand), 2017 – 2022
    Figure-42:    Switzerland – Forecast for Reusable Insulin Pen User (Thousand), 2023 – 2028
    Figure-43:    Switzerland – Smart Insulin Pen User (Thousand), 2017 – 2022
    Figure-44:    Switzerland – Forecast for Smart Insulin Pen User (Thousand), 2023 – 2028
    Figure-47:    Switzerland – Insulin Pump Market for Type 1 Diabetes Market (Million US$), 2017 – 2023
    Figure-48:    Switzerland – Forecast for Insulin Pump Market for Type 1 Diabetes Market (Million US$), 2023 – 2028
    Figure-49:    Switzerland – Insulin Pump Market for Type 2 Diabetes Market (Million US$), 2017 – 2023
    Figure-50:    Switzerland – Forecast for Insulin Pump Market for Type 2 Diabetes Market (Million US$), 2023 – 2028
    Figure-51:    Switzerland – Insulin Pump Type 1 Users (Thousand), 2017 – 2022
    Figure-52:    Switzerland – Forecast for Insulin Pump Type 1 Users (Thousand), 2023 – 2028
    Figure-53:    Switzerland – Insulin Pump Type 2 Users (Thousand), 2017 – 2022
    Figure-54:    Switzerland – Forecast for Insulin Pump Type 2 Users (Thousand), 2023 – 2028
    Figure-55:    B. Braun Melsungen AG – Global Revenue (Billion US$), 2017 – 2022
    Figure-56:    B. Braun Melsungen AG – Forecast for Global Revenue (Billion US$), 2023 – 2028
    Figure-57:    Eli Lilly – Global Revenue (Million US$), 2017 – 2022
    Figure-58:    Eli Lilly – Forecast for Global Revenue (Million US$), 2023 – 2028
    Figure-59:    Terumo Corporation – Global Revenue (Billion US$), 2017 – 2022
    Figure-60:    Terumo Corporation – Forecast for Global Revenue (Billion US$), 2023 – 2028
    Figure-61:    BD – Global Revenue (Billion US$), 2017 – 2022
    Figure-62:    BD – Forecast for Global Revenue (Billion US$), 2023 – 2028
    Figure-63:    Novo Nordisk A/S – Global Revenue (Million US$), 2017 – 2022
    Figure-64:    Novo Nordisk A/S – Forecast for Global Revenue (Million US$), 2023 – 2028
    Figure-65:    Ypsomed AG – Global Revenue (Million US$), 2017 – 2022
    Figure-66:    Ypsomed AG – Forecast for Global Revenue (Million US$), 2023 – 2028
    Figure-67:    Medtronic – Global Revenue (Billion US$), 2017 – 2022
    Figure-68:    Medtronic – Forecast for Global Revenue (Billion US$), 2023 – 2028
    Figure-69:    Insulet Corporation – Global Revenue (Million US$), 2017 – 2022
    Figure-70:    Insulet Corporation – Forecast for Global Revenue (Million US$), 2023 – 2028
    Figure-71:    DarioHealth Corp – Global Revenue (Million US$), 2017 – 2022
    Figure-72:    DarioHealth Corp – Forecast for Global Revenue (Million US$), 2023 – 2028
    Figure-73:    Abbott Laboratories – Global Revenue (Billion US$), 2017 – 2022
    Figure-74:    Abbott Laboratories – Forecast for Global Revenue (Billion US$), 2023 – 2028
    Figure-75:    Dexcom Inc – Global Revenue (Billion US$), 2017 – 2022
    Figure-76:    Dexcom Inc – Forecast for Global Revenue (Billion US$), 2023 – 2028
    Figure-77:    Roche – Global Revenue (Billion US$), 2017 – 2022
    Figure-78:    Roche – Forecast for Global Revenue (Billion US$), 2023 – 2028
    Figure-79:    Tandem Diabetes Care – Global Revenue (Million US$), 2017 – 2022
    Figure-80:    Tandem Diabetes Care – Forecast for Global Revenue (Million US$), 2023 – 2028


    List of Tables:

    Table-01:    Switzerland – Diabetes Market Share by Type (Percent), 2017 – 2022
    Table-02:    Switzerland – Forecast for Diabetes Market Share by Type (Percent), 2023 – 2028

    • Description
      Price
    • Chapter 1 & 4     Pages : 7
      $300
    • Chapter 6     Pages : 4
      $300
    • Chapter 8     Pages : 7
      $300
    • Chapter 9     Pages : 21
      $1,000
    • Chapter 10     Pages : 15
      $700
    • Chapter 11     Pages : 9
      $400
    • Chapter 12.1     Pages : 5
      $150
    • Chapter 12.2     Pages : 5
      $150
    • Chapter 12.3     Pages : 5
      $150
    • Chapter 12.4     Pages : 5
      $150
    • Chapter 12.5     Pages : 5
      $150
    • Chapter 12.6     Pages : 5
      $150
    • Chapter 13.1     Pages : 5
      $150
    • Chapter 13.2     Pages : 5
      $150
    • Chapter 14.1     Pages : 5
      $150
    • Chapter 14.2     Pages : 5
      $150
    • Chapter 15.1     Pages : 5
      $150
    • Chapter 15.2     Pages : 5
      $150
    • Chapter 15.3     Pages : 5
      $150

    Related Reports